Ottimo Pharma Limited
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors (NCT07266428) | Ottimo Pharma Limited | 2025-12-17 |
Track Ottimo Pharma Limited automatically
Every clearance here is in the API, with alerts when new ones post.